Publications

Electrocardiographic effects of four antimalarials for pregnant women with uncomplicated malaria on the Thailand-Myanmar border: a randomised controlled trial.

Saito M. et al, (2021), Antimicrobial agents and chemotherapy

Serological evidence indicates widespread distribution of rickettsioses in Myanmar.

Elders PND. et al, (2020), International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 103, 494 - 501

Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study

Imwong M. et al, (2020), The Lancet Infectious Diseases, 20, 1470 - 1480

Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

Saito M. et al, (2020), BMC Medicine, 18

The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network

Hossain MS. et al, (2020), PLOS Medicine, 17, e1003393 - e1003393

Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis

Saito M. et al, (2020), The Lancet Infectious Diseases, 20, 943 - 952

Plasmodium falciparum ATP4 inhibitors to treat malaria: worthy successors to artemisinin?

Ashley EA. and Phyo AP., (2020), The Lancet. Infectious diseases, 20, 883 - 885

Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial

van der Pluijm RW. et al, (2020), The Lancet, 395, 1345 - 1360

Evaluation of the forum theatre approach for public engagement around antibiotic use in Myanmar.

Swe MMM. et al, (2020), PloS one, 15

Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments—a WWARN individual patient data meta-analysis

(2019), BMC Medicine, 17

Genomic structure and diversity of Plasmodium falciparum in Southeast Asia reveal recent parasite migration patterns

Shetty AC. et al, (2019), Nature Communications, 10

The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis

Commons RJ. et al, (2019), BMC Medicine, 17

An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples

Pearson RD. et al, (2019)

The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis

Commons RJ. et al, (2019), PLOS Medicine, 16, e1002928 - e1002928

New malaria maps

Nosten FH. and Phyo AP., (2019), The Lancet, 394, 278 - 279

Plasmodium vivax Relapse Rates Following Plasmodium falciparum Malaria Reflect Previous Transmission Intensity

Ashley EA. et al, (2019), The Journal of Infectious Diseases, 220, 100 - 104

Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria

Chu CS. et al, (2019), Clinical Infectious Diseases, 68, 1311 - 1319

EFFICACY AND TOLERABILITY OF ARTEMISININ- AND QUININE-BASED TREATMENTS FOR UNCOMPLICATED FALCIPARUM MALARIA DURING PREGNANCY: A WWARN INDIVIDUAL PATIENT DATA META-ANALYSIS

Saito M. et al, (2019), AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 101, 81 - 81

Poor response to artesunate treatment in two patients with severe malaria on the Thai–Myanmar border

Phyo AP. et al, (2018), Malaria Journal, 17

The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background

Zhu L. et al, (2018), Nature Communications, 9